Search
Search our content by date or relevance.
The future value of auditing from an industry perspective
Cheekeong Loh, CQP MCQI, MIEAust CPEng, outlines how auditing can develop in the future.
Managing supply chains post Brexit
Malcolm Harrison, Group CEO of the Chartered Institute of Procurement & Supply (CIPS), talks to Daniel Moore about how Brexit will impact supply chains and logistics in 2021.
Adapting to the new normal: third-party audits
Damien Tiller, CQP MCQI, IRCA Lead PQMS and QMS Auditor, highlights the way the SOC® Service Organizations: Trust Services Criteria Report could overcome the difficulties inherent in remote auditing.
Ensuring a smooth transition post Brexit
Daniel Moore speaks with Scott Steedman, Director of Standards at BSI, to find out how the organisation is preparing for the challenges of Brexit.
Auditing in the 'new normal'
Roland Tan, Principal Consultant/Director at EQOSH Management Pty Ltd, Australia, provides some key considerations and guidance for performing audits in the ‘new normal’.
Maintaining quality standards in disruptive times through internal audits
Youmna Abboud, Quality Assurance and Regulatory Affairs Associate at Zimmer Biomet, Middle East, explains why internal audits are required during the coronavirus pandemic.
Setting and applying SMART objectives
Sam Kinch, Quality Management Consultant at qualityinspired.co.uk, highlights the importance of SMART objectives and how businesses should apply them.
Risk-based thinking
Luis Alberto Palacios Vásquez, Technical Director at Integral Consulting Group, Guatemala, South America, explains the importance of risk-based thinking during the audit process.
The new normal for remote audits
Amy Schewe, CQP PCQI, Quality Manager at Thin Metal Parts in Colorado Springs, US, explains how remote audits can help auditors with conducting successful audits during and after the coronavirus pandemic.
Keeping up with supplier demand
As the coronavirus pandemic continues, Jennifer Feasby, Quality Manager at Hart Biologicals, UK, speaks to Daniel Moore about how the company has continued to supply In Vitro Devices to customers, while tackling the challenges and threats posed by Covid-19.